RECURRENT OVARIAN CANCER TREATED BY SECONDARY CYTOREDUCTIVE SURGERY AND HIPEC

被引：0
|
作者：
Panoskaltsis, T. [1 ]
Tzavara, C. [2 ]
Pallas, N. [3 ]
Karamveri, C. [3 ]
Kiziridis, D. [4 ]
Hristakis, C. [4 ]
Kyriakopoulos, V. [3 ]
Kalakonas, A. [4 ]
Vaikos, D. [4 ]
Tentes, A-A [3 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Gynaecol Oncol Unit, Sch Med, Acad Dept 2,Aretaieion, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[3] Metropolitan Hosp, Dept Surg Oncol, Peritoneal Surface Malignancy Program, Athens, Greece
[4] Euromed Kyanous Stavros, Dept Surg Oncol, Peritoneal Surface Malignancy Program, Thessaloniki, Greece
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP947
引用
收藏
页码：A505 / A506
页数：2
相关论文
共 50 条
  • [31] Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Petrillo, M.
    De Iaco, P.
    Cianci, S.
    Perrone, M.
    Costantini, B.
    Ronsini, C.
    Scambia, G.
    Fagotti, A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1660 - 1665
  • [32] Pharmacokinetic analysis of hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin during secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer
    Byrne, M. E.
    Chi, D. S.
    O'Cearbhaill, R.
    Beumer, J. H.
    Guo, J.
    Zivanovic, O.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 120 - 121
  • [33] Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
    Lee, Dowon
    Lee, Jinhye
    Park, Hyemin
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    GLAND SURGERY, 2023, 12 (12) : 1696 - 1704
  • [34] The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score
    Balieiro Anastacio da Costa, Alexandre Andre
    Valadares, Camila V.
    Mantoan, Henrique
    Saito, Augusto
    Salvadori, Marcella Marinelli
    Guimaraes, Andreia Paiva
    Sanches, Solange Moraes
    de Souza Wadington Achatz, Maria Isabel Alves
    Baiocchi, Glauco
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (03) : 449 - 455
  • [35] Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
    Zang, Rongyu
    Zhu, Jianqing
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)
  • [36] Secondary cytoreductive surgery for recurrent ovarian cancer: who will get the most benefit?
    Son, Joo-Hyuk
    Yum, Sun Hyung
    Kong, Tae-Wook
    Paek, Jiheum
    Chang, Suk-Joon
    Ryu, Hee-Sug
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S7 - S7
  • [37] Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
    Panici, Pierluigi Benedetti
    De Vivo, Antonio
    Bellati, Filippo
    Manci, Natalina
    Perniola, Giorgia
    Basile, Stefano
    Muzii, Ludovico
    Angioli, Roberto
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1136 - 1142
  • [38] The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC)
    Cheng, X.
    Jiang, R.
    Li, Z. T.
    Tang, J.
    Cai, S. M.
    Zhang, Z. Y.
    Tian, W. J.
    Zang, R. Y.
    EJSO, 2009, 35 (10): : 1105 - 1108
  • [39] Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Kim, Kidong
    Ryu, Sang-Young
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 30 (03) : 198 - 198
  • [40] Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Pierluigi Benedetti Panici
    Antonio De Vivo
    Filippo Bellati
    Natalina Manci
    Giorgia Perniola
    Stefano Basile
    Ludovico Muzii
    Roberto Angioli
    Annals of Surgical Oncology, 2007, 14 : 1136 - 1142
12345